Open Access · CC BY-NC 3.0
Dipyridamole as a Perioperatively Safe Aurora Kinase A Inhibitor for Neoadjuvant Therapy in Esophageal Squamous Cell Carcinoma
OncoTargets and Therapy · 2026-09 · Volume 19 · 1-14
DOI: 10.2147/ott.s620767 ↗Kurz gefasst
Fachartikel in der Zeitschrift OncoTargets and Therapy, 2026-09. Verfasst von Jiawen Song. Beteiligte Einrichtung: Shanghai Fengxian District Central Hospital, Shanghai, China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
aurora kinase Adrug repurposingesophageal squamous cell carcinomaneoadjuvant therapyperioperative safety
Autor:innen und Institutionen
- Shanghai Fengxian District Central Hospital, Shanghai, China.
Zitieren
APA
Song, J. (2026). Dipyridamole as a Perioperatively Safe Aurora Kinase A Inhibitor for Neoadjuvant Therapy in Esophageal Squamous Cell Carcinoma. OncoTargets and Therapy, Volume 19, 1-14. https://doi.org/10.2147/ott.s620767
Vancouver
Song J. Dipyridamole as a Perioperatively Safe Aurora Kinase A Inhibitor for Neoadjuvant Therapy in Esophageal Squamous Cell Carcinoma. OncoTargets and Therapy. 2026;Volume 19:1-14. doi:10.2147/ott.s620767
BibTeX
@article{Song2026,
author = {Song, Jiawen},
title = {Dipyridamole as a Perioperatively Safe Aurora Kinase A Inhibitor for Neoadjuvant Therapy in Esophageal Squamous Cell Carcinoma},
journal = {OncoTargets and Therapy},
year = {2026},
volume = {Volume 19},
pages = {1--14},
doi = {10.2147/ott.s620767}
}
EUVIMED